JD010
/ Beijing JD Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 09, 2022
CAR-NK Targeted CD19 for r/r B-cell Malignancies
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: Affiliated Hospital to Academy of Military Medical Sciences
New P1 trial • Hematological Disorders • Hematological Malignancies • Oncology • CD19
1 to 1
Of
1
Go to page
1